iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Adverse Drug Reactions (ADRs)

Adverse Drug Reactions (ADRs)

Recognition, management, and reporting of ADRs.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
PharmacologyAllergyGeneral Practice

Clinical Guidelines

CKS: Adverse Drug Reactions
National
Guideline For Adverse Drug Reactions (ADRs) Reporting for Healthcare Professionals
Local
ICH Harmonised Tripartite Guideline: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (E2A)
Local
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Topic E 2 Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
Local
Send and receive information on adverse drug reactions (ADRs): Guidance
Local
Severe cutaneous adverse reactions (SCAR): CIOMS Consensus Report
Local
The Yellow Card scheme: guidance for healthcare professionals
Local

Recent iatroX Q&As

  • What steps should I take to assess a patient presenting with suspected adverse drug reactions?Updated: 8/22/2025
  • What are the recommended guidelines for reporting adverse drug reactions in the UK?Updated: 8/22/2025
  • Which common medications are most frequently associated with adverse drug reactions in primary care?Updated: 8/22/2025
  • How should I manage a patient who has experienced an adverse drug reaction to a medication they are currently taking?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play